Catálogo de publicaciones - libros
Título de Acceso Abierto
Cancer Biomarker Research and Personalized Medicine
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
clear cell renal cell carcinoma; radiomics; WHO/ISUP nuclear grade; multiphasic multidetector computed tomography; triple-negative breast cancer; taxane; chemotherapy; GBP5; Akt/mTOR; autophagy; IL13Rα2; renal cell carcinoma; JAK2; FOXO3; telmisartan; ovarian cancer; bioinformatics; CREB1; drug perturbation; lincRNA-p21; rectal cancer; chemoradiotherapy; colorectal cancer; long non-coding RNA; p53; predictive biomarker; intestinal anastomosis; anastomotic leak; biomarkers; precision medicine; personalized medicine; biomarker; AmpliSeq; DNA methylation; epigenetics; head and neck cancer; saliva; liquid biopsy; meta-analysis; gastric cancer; middle-up-down; haptoglobin; glycopeptide; mass spectrometry; circulating tumor cells; prostate cancer; cancer vaccine; immune response; breast cancer; predictive tools; prognostic tools; translational research; IL6ST; gp130; cytokine signalling; tissue-based biomarkers; liquid-based biomarkers; radiotherapy; radiosensitivity biomarkers; secretome; radioresistance; bladder tumor; lymphocyte-to-monocyte ratio; peripheral blood parameters; tumor recurrence; transurethral resection; lipidomics; 1H-NMR; LC-MS/MS; lipoprotein subfractions; lipoprotein lipase; cancer biomarkers; hepatocellular carcinoma; p16 expression; head and neck squamous cell carcinoma; HPV genotyping; exosomes; chemoresistance; comparative oncology; One Health; microRNA; lymph node metastasis; hormone-dependent carcinogenesis; localized prostate cancer; prognostic factors; HNSCC; n/a
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No requiere | Directory of Open access Books |
Información
Tipo de recurso:
libros
ISBN electrónico
978-3-0365-3917-1
País de edición
Suiza